Merck Wins Big Against Rivals in Lung Cancer Study Survival Rates
Lung cancer may have just met a new standard of care. On top of that, it would be considered a new standard as a first line of care in lung cancer and ...Read Full Story »
Nektar Therapeutics (NASDAQ:NKTR)
Read Full Story »
Jefferies Has 4 Red-Hot Growth Stocks to Buy Despite Volatility
One thing's for sure: if the last two weeks haven’t left some investors a little shell-shocked, then they are lying or they sold out in front of all the selling. ...Read Full Story »
50 Mid-Cap and Larger Stocks More Than Doubled in 2017
With 2017 nearing an end, it is important to consider just what has happened. Tax reform looks very likely now, and gross domestic product is higher in the United States ...Read Full Story »
Top Analyst Upgrades and Downgrades: Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square, T-Mobile, Wix.com and More
After a week of stocks seeming to look for a direction, while still bumping up against all-time highs, the major stock indexes were all indicated handily lower on Thursday morning. ...Read Full Story »
Top Analyst Upgrades and Downgrades: Altice USA, CVS Health, Exxon, Lowe’s, T-Mobile, Sprint, Under Armour and More
Stocks closed marginally higher on Monday and were looking for direction on Tuesday. The bull market may be nine years old and stocks may be right at all-time highs, but ...Read Full Story »
Top Analyst Upgrades and Downgrades: BlackBerry, BP, Camping World, Deere, GrubHub, KLA-Tencor, Teva, Zions and More
Stocks were looking for direction on Monday. Despite the Dow having crossed 22,000 for the first time, we are now more than a week with days of gains, and this ...Read Full Story »
Top Analyst Upgrades and Downgrades: AK Steel, Amazon, AngloGold Ashanti, Bank of America, GE, Disney, Xilinx and More
Stocks were indicated to open sharply higher on Monday after the French election outcome favored Macron and therefore no threat to the EU existence. Even though this bull market is ...Read Full Story »
Top Analyst Upgrades and Downgrades: Carnival, Facebook, Freeport-McMoRan, Motorola Solutions, Procter & Gamble and Many More
24/7 Wall St. reviews dozens of analyst research reports each day of the week. The goal is to find new investing and trading ideas for our readers. Some analyst reports ...Read Full Story »
Monday’s Top Biopharma Movers
A few biopharma stocks made massive runs on Monday morning. The broad markets are holding near their all-time highs, and part of the run up to this level is attributed ...Read Full Story »
Top Analyst Upgrades and Downgrades: Cognizant Tech, Etsy, GoPro, Illumina, Shake Shack, Travelers and More
Stocks were indicated to open marginally lower after a more or less inline payrolls report from the Labor Department. The Dow was indicated down 21 points and the S&P 500 ...Read Full Story »
Massive Energy Trade Highlights Insider Blue Chip Buying: Kinder Morgan, AT&T, Kimberly-Clark, IBM, Johnson & Johnson and More
With the busiest earnings week behind us, it appears some of the restriction windows at major U.S. corporations are starting to open up a little. While the volume was still ...Read Full Story »
Nektar Slides on Secondary Offering Pricing
Nektar Therapeutics (NASDAQ: NKTR) has filed with the U.S. Securities and Exchange Commission (SEC) for a secondary offering. The company plans to price its 13 million shares at $13.50, with ...Read Full Story »
Top Analyst Upgrades and Downgrades: Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK, Tableau and Many More
Stocks were getting pounded on Monday after a rough Friday, on the continuation of oil and a weak Europe, even as China was closed for Chinese New Year. The stock ...Read Full Story »
Huge Biotech Index Rebalance Means Massive Buy Orders for 5 Stocks
On the close Friday, the NYSE Arca Biotechnology Index is set for a rebalance. What this means is the index will be rebalanced to reflect reweighting allocations across the stocks ...Read Full Story »
5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015
The health care sector and biotech in particular have been on fire so far in 2015, but some biotech stocks in the group just are not carrying their weight. The ...Read Full Story »
-
Categories
- Aerospace & Defense (1,214)
- Apps & Software (862)
- Autos (3,484)
- Banking & Finance (4,448)
- Casinos & Hotels (207)
- Commodities & Metals (1,738)
- Consumer Products (1,986)
- Economy (4,006)
- Energy Business (5,241)
- Energy Economy (1,408)
- General (29)
- Healthcare Business (3,615)
- Healthcare Economy (327)
- Housing (2,322)
- Industrials (951)
- Infrastructure (439)
- Investing (28,604)
- Jobs (1,061)
- Media (5,442)
- Retail (4,595)
- Services (1,055)
- Special Report (2,035)
- Sponsored Content (2)
- Technology (5,264)
- Telecom & Wireless (2,105)
- Transportation (768)
